Handelsbanken Fonder Ab Amryt Pharma PLC Transaction History

Handelsbanken Fonder Ab

  • $23 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 28, 2023
SELL
$7.0 - $14.77 $6.24 Million - $13.2 Million
-891,468 Reduced 62.93%
525,178 $7.66 Million
Q4 2022

Feb 07, 2023
BUY
$6.68 - $7.58 $274,180 - $311,121
41,045 Added 2.98%
1,416,646 $10.3 Million
Q2 2022

Aug 03, 2022
BUY
$6.85 - $8.87 $411,000 - $532,200
60,000 Added 4.56%
1,375,601 $9.62 Million
Q1 2022

May 11, 2022
BUY
$6.3 - $10.86 $8.29 Million - $14.3 Million
1,315,601 New
1,315,601 $10.9 Million

Others Institutions Holding AMYT

# of Institutions
5
Shares Held
142K
Call Options Held
0
Put Options Held
0
View Full List

About Amryt Pharma plc

AMYT Quotes by TradingView
  • Ticker AMYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 64,177,000
  • Description
  • Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with ...
More about AMYT
Track This Portfolio

Track Handelsbanken Fonder Ab Portfolio

Follow Handelsbanken Fonder Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email